Bolt Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.
BOLT Key Statistics
Stock Snapshot
As of today, Bolt Biotherapeutics(BOLT) shares are valued at $6.39. The company's market cap stands at 12.1M, with a P/E ratio of -0.38.
On 2026-11-12, Bolt Biotherapeutics(BOLT) stock moved within a range of $6.18 to $6.39. With shares now at $6.39, the stock is trading +3.4% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 42.68K, compared to an average daily volume of 107.4K.
Over the past 52 weeks, Bolt Biotherapeutics(BOLT) stock has traded between a high of $7.78 and a low of $3.10.
Over the past 52 weeks, Bolt Biotherapeutics(BOLT) stock has traded between a high of $7.78 and a low of $3.10.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.